illuminem logo
illuminem logo
  • Rankings
  • Use Cases
  • Pricing
  • Media
  • More
illuminem logo

About illuminem

AboutCareersBecome a Thought Leader

Advertising

Advertise with usPromote EventsOur Reach

Support

FAQsContact Us
Terms & Privacy Policy

© 2026 illuminem. All rights reserved. Various trademarks held by their owners.

  1. Home
  2. ›
  3. Industries
  4. ›
  5. health care
  6. ›
  7. Blau Farmaceutica
Company logo

Blau Farmaceutica | Sustainability Performance

https://www.blau.com/

A pharmaceutical company involved in the research, production, and commercialization of specialty medicines. Its portfolio includes injectable drugs and biological products aimed at hospital and institutional use, with operations extending across several countries.

1987

Brazil

1,001 - 5,000 employees

Pharmaceuticals

$100M - 500M in revenue

$25M - 100M in profitability

Submit or report inaccurate dataDownload Company InsightsⓘBy downloading this report, you'll receive the most insightful and detailed analysis of the company's sustainability performance, compared to its peers. It includes key industry trends, carbon and energy intensity, nature impact, social metrics, and an in-depth look at key risks and controversies.

Sustainability Ranking & Industry Benchmark

#8223
Overallⓘ
#81
in Brazilⓘ
#192
in Pharmaceuticalsⓘ

Sustainability Maturity

ⓘ
​​0123456789​​%

Sustainability Intent

ⓘ

Available in
Scale package

Access
​​0123456789​​%

Beyond Top 100

Overview
Financial Data
Business performanceCapital & innovationAnalyst projections

View similiar companies

Company logo
Hypera

Brazil, Health Care, Pharmaceuticals

Company logo
Industri Jamu Dan Farmasi Sido Muncul

Indonesia, Health Care, Pharmaceuticals

Company logo
Canopy Growth

Canada, Health Care, Pharmaceuticals

Market cap ⓘTotal market value of the company's outstanding shares, calculated by multiplying the share price by the number of shares outstanding.
2.5B$, 2026▲3.3% YoY
Revenue ⓘTotal revenue reported in the company's financial statements for the specified reporting year, reflecting income generated from primary business activities. Expressed in millions of USD.
1.8B$, 2024▼21.8% YoY
R&D intensity ⓘResearch and development expenditure expressed as a percentage of revenue, reflecting the company's relative investment in innovation.
1.71%2024

Controversy level

Very Low
Low
Noticeable
High
Severe
Download Controversy Analysis
Powered by illuminem

Reporting

sustainability report symbol

Sustainability Report

 Available
Not committed to key sustainability initiatives

Sustainability employees

ⓘWe follow the strictest rules to ensure compliance with all the relevant data protection laws, including GDPR. Click here for our Privacy Policy.

Total sustainability employees

11+

ⓘThis value represents the estimated number of employees in a company with sustainability-related roles or job titles, as determined by Illuminem using publicly available data.

    Available in
    Scale package

    Access
  • Email
  • Email